Nurix Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRIX and other ETFs, options, and stocks.About NRIX
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.
CEOArthur T. Sands
CEOArthur T. Sands
Employees284
Employees284
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2009
Founded2009
Employees284
Employees284
NRIX Key Statistics
Market cap1.49B
Market cap1.49B
Price-Earnings ratio-7.90
Price-Earnings ratio-7.90
Dividend yield—
Dividend yield—
Average volume690.76K
Average volume690.76K
High today$23.55
High today$23.55
Low today$23.02
Low today$23.02
Open price$23.55
Open price$23.55
Volume215.47K
Volume215.47K
52 Week high$26.31
52 Week high$26.31
52 Week low$4.22
52 Week low$4.22
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%